Patents by Inventor Jared Wiig

Jared Wiig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Clostridium botulinum Serotype A Neurotoxin (BoNT/A) Sequence Variants
    Publication number: 20240277820
    Abstract: Provided herein are compositions comprising a Clostridium botulinum neurotoxin serotype A (BoNT/A) complex comprising a 150 kDa BoNT/A. Said 150 kDa BoNT/A is in the form of a plurality of sequence variant species, wherein the plurality of sequence variant species comprises a 150 kDa BoNT/A sequence variant species with a C-terminal truncated light chain.
    Type: Application
    Filed: January 19, 2024
    Publication date: August 22, 2024
    Applicant: AbbVie Inc.
    Inventors: Robert R. Kehrer, Jared Wiig, Hui Xiang, Phillip P. Nguyen, Hemant A. Patel, Connie J. Ng, Cortnie M. Guerrero
  • CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A COMPOSITIONS
    Publication number: 20240245760
    Abstract: The present disclosure relates to Clostridium botulinum neurotoxin serotype A (BoNT/A) compositions with a plurality of 900 kDa Clostridium botulinum neurotoxin serotype A (BoNT/A) complex species. Provided herein are compositions comprising BoNT/A that have a low level of oxidation at specific methionine positions of 150 kDa BoNT/A. Further provided herein are methods of producing a composition comprising BoNT/A using a low temperature during the process of fermenting Clostridium botulinum bacteria.
    Type: Application
    Filed: January 19, 2024
    Publication date: July 25, 2024
    Applicant: AbbVie Inc.
    Inventors: Robert R. Kehrer, Jared Wiig, Hui Xiang, Phillip P. Nguyen, Hemant A. Patel, Connie J. Ng, Cortnie M. Guerrero